(Medical Xpress)—A new study out today reveals that the emergence and spread of a rapidly evolving invasive intestinal disease, that has a significant mortality rate (up to 45%) in infected people in sub-Saharan Africa, ...
Sep 30, 2012
1
0
If smoking a cigarette no longer delivers pleasure, will smokers quit? It's the idea behind a nicotine vaccine being created by MIT and Harvard researchers, in which an injection of synthetic nanoparticles prompts the immune ...
(Medical Xpress) -- Malaria is a disease caused by parasites passed to humans via the bites of infected mosquitoes. Globally, the disease causes over a million deaths every year, and is especially rife in parts of Africa ...
One injected dose of an experimental malaria monoclonal antibody was 77% effective against malaria disease in children in Mali during the country's six-month malaria season, according to the results of a mid-stage clinical ...
1 hour ago
0
0
Researchers from NDORMS in collaboration with international institutions have demonstrated the potential of using environmental measurements and deep learning modeling to predict malaria outbreaks in South Asia. The study ...
Apr 24, 2024
0
7
A group of researchers is calling on colleagues around the world to join them in what they call "pathogen prospecting" by tracking down archival specimens of mosquitoes in museums and other collections to examine them for ...
Apr 1, 2024
0
15
Genetic diversity of the malaria parasite in pregnant women and children declined in an area targeted for malaria elimination in Mozambique, according to a study led by the Barcelona Institute for Global Health (ISGlobal). ...
Mar 19, 2024
0
20
Children with acute malnutrition across Africa and Asia have a higher risk of treatment failure and malaria reinfection, even after being given the best currently available and recommended malaria treatment. Researchers from ...
Mar 13, 2024
0
14
Researchers from The Australian National University (ANU) have discovered a previously unknown ability of a group of immune system cells, known as atypical B cells (ABCs), to fight infectious diseases such as malaria.
Feb 8, 2024
0
13
Phase III trial results of the R21/Matrix-M vaccine developed by Oxford University and Serum Institute of India Pvt Ltd, leveraging Novavax's Matrix-M adjuvant, has confirmed high efficacy and supported regulatory approvals ...
Feb 2, 2024
0
32
